PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Office of Clinical Research, Northwell Health, Lake Success, New York, USA.\', \'Feinstein Institutes for Medical Research, Manhasset, New York, USA.\', \'Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.\', \'Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.\', \'New York City Helath + Hospitals Corporation, New York, New York, USA.\', \'Medical Research Council Cancer Unit, University of Cambridge, Hutchison Research Centre, Cambridge, UK.\', \'Medical School, University of Heidelberg, Heidelberg, Germany.\', \'Northwell Health Cancer Institute, Northwell Health, New Hyde Park, New York, USA.\', \'Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.\', \'Department of Obstetrics and Gynecology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.\', \'Biostatistical Consulting Core, School of Medicine, Stony Brook University, Stony Brook, New York, USA.\', \'Department of Family, Population and Preventive Medicine, School of Medicine, Stony Brook University, Stony Brook, New York, USA.\', \'Department of Neurosurgery, Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.\', \'Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA janowitz@cshl.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/gutjnl-2022-326952
?:hasPublicationType
?:journal
  • Gut
is ?:pmid of
?:pmid
?:pmid
  • 35144974
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.44
?:rankingScore_hIndex
  • 251
is ?:relation_isRelatedTo_publication of
?:title
  • Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all